Filing Details
- Accession Number:
- 0001209191-19-028879
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-10 16:13:02
- Reporting Period:
- 2019-05-08
- Accepted Time:
- 2019-05-10 16:13:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194459 | F William Doyle | C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-05-09 | 31,460 | $47.37 | 896,463 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Options to Buy Ordinary Shares | Acquisiton | 2019-05-08 | 115,060 | $0.00 | 115,060 | $47.56 |
| Ordinary Shares | Options to Buy Ordinary Shares | Acquisiton | 2019-05-08 | 35,000 | $0.00 | 35,000 | $47.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 115,060 | 2029-05-08 | No | 4 | A | Direct | |
| 35,000 | 2029-05-08 | No | 4 | A | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Options to buy 115,060 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $59.45 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Doyle has been continuously employed by the Company through May 8, 2022.
- Options to buy 35,000 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $71.34 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Doyle has been continuously employed by the Company through May 8, 2022.
Billionaire Hedge Funds
